Global Initiative for Obstructive Lung Disease (GOLD) Criteria for COPD

ورودی‌های بالینی بیمار

حداقل ۱۰ — حداکثر ۱۲۰ • واحد: % predicted

حداقل ۰.۳ — حداکثر ۱ • واحد: ratio

حداقل ۰ — حداکثر ۴۰ • واحد: points

حداقل ۰ — حداکثر ۲۰ • واحد: episodes

حداقل ۰ — حداکثر ۱۰ • واحد: admissions

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
gold classification
—stage
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • GOLD 1 - Mild COPD80–120
  • GOLD 2 - Moderate COPD50–79
  • GOLD 3 - Severe COPD30–49
  • GOLD 4 - Very Severe COPD10–29

Clinical Decision Pathway

Clinical Decision Pathway & Next Steps

Respiratory & Pneumonia — بیماری‌های تنفسی، پنومونی و COPD

Clinical Rationale:

Stratify community-acquired pneumonia with CURB-65 and PSI/PORT; monitor ROX during high-flow oxygen for intubation avoidance, and guide acute COPD exacerbation with BAP-65, DECAF, and GOLD criteria.

← Previous Step in PathwayPrior step

DECAF Score for Acute Exacerbation of COPD

امتیاز DECAF (مرگ‌ومیر بستری در COPD)

Review previous tool

Recommended Clinical Next Steps:

  • BODE Index for COPD Survival

    شاخص بقای BODE در COPD

    Why next: Long-term multidimensional mortality prediction in COPDForward Escalation — Next Clinical Phase
Direct Clinical Answer

The Global Initiative for Obstructive Lung Disease (GOLD) Criteria for COPD calculator is designed for bedside stratifying pneumonia severity, respiratory failure progression, and inpatient admission requirements in clinical practice. The resulting score directly guides clinician decision-making regarding determining appropriate admission level (floor versus ICU), tailoring.

Clinical Guidelines & Evidence

Clinical assessment and staging system for chronic obstructive pulmonary disease (COPD) based on spirometry, symptoms, and exacerbation risk. Provides comprehensive evaluation using FEV1 percentage predicted, symptom assessment, and treatment recommendations according to GOLD 2024-2025 guidelines.

Clinical Indication

The Global Initiative for Obstructive Lung Disease (GOLD) Criteria for COPD is indicated for bedside clinical practice to support Clinical assessment and staging system for chronic obstructive pulmonary disease (COPD) based on spirometry, symptoms, and exacerbation risk. Provides comprehensive evaluation using FEV1 percentage predicted, symptom assessment, and treatment recommendations according to GOLD 2024-2025 guidelines.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.

Limitations & Contraindications

Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.

Clinical Pearls & Action Plan

Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management. Guideline pearl: Blood eosinophil count influences ICS treatment decisions.

Formula & Variables:

GOLD Stage = FEV1% predicted category (1-4); COPD Group = Symptoms (mMRC/CAT) + Exacerbation risk assessment; Treatment guided by ABE assessment tool

Input Parameters

NameTypeRequiredDescription
fev1_percent_predictedfloatYesForced expiratory volume in 1 second (FEV1) as percentage of predicted normal value based on post-bronchodilator spirometry(% predicted)
fvc_fev1_ratiofloatYesPost-bronchodilator FEV1/FVC ratio. Values <0.70 confirm airflow obstruction and COPD diagnosis(ratio)
dyspnea_mmrcintegerYesModified Medical Research Council (mMRC) Dyspnea Scale: 0=breathless only with strenuous exercise, 1=short of breath when hurrying, 2=walks slower than people of same age, 3=stops for breath after walking ~100m, 4=too breathless to leave house(grade)
cat_scoreintegerNoCOPD Assessment Test (CAT) score (0-40 points). Alternative to mMRC for symptom assessment. Scores ≥10 indicate significant symptom burden(points)
exacerbations_last_yearintegerYesNumber of COPD exacerbations in the last 12 months requiring oral corticosteroids and/or antibiotics(episodes)
hospitalizations_last_yearintegerYesNumber of COPD-related hospitalizations in the last 12 months due to exacerbations(admissions)

Score Interpretation & Guidance

RangeStageDescription
80–120GOLD 1 - Mild COPDMild airflow limitation
50–79GOLD 2 - Moderate COPDModerate airflow limitation
30–49GOLD 3 - Severe COPDSevere airflow limitation
10–29GOLD 4 - Very Severe COPDVery severe airflow limitation

Evidence-Based References (EBM)

  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2025 Report. Available from: https://goldcopd.org/
  • Singh SJ, Augustin IML, Correia de Sousa R, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447-1478. doi: 10.1183/09031936.00150414.DOI: 10.1183/09031936.00150414
  • Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-654. doi: 10.1183/09031936.00102509.DOI: 10.1183/09031936.00102509
  • Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586. doi: 10.1136/thx.54.7.581.DOI: 10.1136/thx.54.7.581

Related calculators